5The Serious Hazards of Transfusion Steering Group'. Serious hazards of transfusion: annual report 2006[ OL]. http://www, shotuk. org/SHOT report_2006, pdf.
6Amdt PA, Garratty G. A retrospective analysis of the value of monocytemonolayerassay results for predicting the clinical significance of blood group alloantibodies [ J ]. Transfusion, 2004,44 (9) :1273-1281.
7Chapman JF, Elliott C, Knowles SM, et al. Guidelines for compatibility procedures in blood transfusion laboratories [ J ]. Transfus ned,2004,14( 1 ) :59-73.
8Heddle NM, O Hoski P, Singer J, et al. A prospective study to determine the safety of omitting the antig~obulin erossmateh from pretransfusion testing [ J ]. Br J Haematol, 1992,81 (4) :579-584.
9Shulman IA, Nelson JM, Nakayama R. When should antibody screening tests be done for recently transfused patients [ J ]. Transfusion, 1990,30 ( 1 ) : 39-41.
